Published On: Thu, Mar 9th, 2017

ProText Mobility Inc (OTCMKTS:TXTM) Plans To Assess Potential For Performing Human Clinical Trial

ProText Mobility Inc (OTCMKTS:TXTM) a biotech firm engaged in the advancement of pharmaceutical applications for the bioavailable Phytofare® catechin complex, stated that it performed a series of meetings across Mauritius, topped off with a conversation at the State House where CEO, Roger Baylis-Duffield, initiated discussions with Mauritian President, Professor Ameena Gurib-Fakim.

The update

ProText management visited Mauritius assessing the potential for performing an imminent human clinical study on Type II Diabetes. As per company’s update, Mauritius is being assessed as a study site because, as per the International Diabetes Federation and the World Health Organization, the occurrence of Type II Diabetes in nation in 2015 was an international-leading 16.28%.

Universal as of 2013, 8.3% of the total adult population suffer from diabetes, and more worrying is the fact that Type II Diabetes account for about 90% of the instances. In 2014, the IDF projected that diabetes led in 4.9 million yearly deaths.

Among the topics conversed with her excellency was the prevalent of diabetes troubling the nation and the prospective for the firm’s Phytofare® extract to assist cope blood-sugar levels in those distressed. President Gurib-Fakim is a global-renowned researcher specializing in finding medicinal advantages from plant phytonutrients. Pres. Gurib-Fakim and Baylis-Duffield discovered mutual common interests in advancing plant based solutions to aid treat diabetes and other health issues and the desire to develop the biotech market in Mauritius via research and prospective manufacturing opportunities.

Additionally, to meeting the President, the firm met with officials of the St. Aubin tea estate. The firm assessed the extensive St. Aubin holdings and conversed numerous business development prospects. Protext management also organized extensive meetings with the CIDP to assess their research facilities and converse human clinical study opportunities in Mauritius.

Protext CEO reported that it was a remarkable honor to come at the State House to meet and talk with President Gurib-Fakim.

© Copyright 2016 OTC News Magazine. All rights reserved.